Health ❯ Pharmaceuticals ❯ Drug Pricing ❯ Healthcare Policy

Patient Access

U.S. and U.K. Seal Three-Year Zero‑Tariff Pharma Deal Tied to Higher NHS Drug Prices

The U.S. also commits to pause pricing investigations of the U.K. sector during President Trump’s term.